Disruptive insights in psychiatry: Transforming a clinical discipline

Journal of Clinical Investigation

Volumn 119, Issue 4, 2009, Pages 700-705

  Insel, Thomas R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; HALOPERIDOL; LITHIUM; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AKATHISIA; BIPOLAR DISORDER; BRAIN DISEASE; CANADA; CHRONIC DISEASE; CLINICAL TRIAL; CONVALESCENCE; DEPRESSION; DEVELOPMENTAL DISORDER; DRUG COST; DRUG EFFICACY; DRUG MARKETING; EXTRAPYRAMIDAL SYMPTOM; GENETIC DISORDER; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHIATRY; PUBLIC HEALTH SERVICE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SIDE EFFECT; UNITED STATES; WEIGHT GAIN; EDITORIAL; PUBLIC HEALTH;

HUMANS; MENTAL DISORDERS; PSYCHIATRY; PUBLIC HEALTH;

EID: 65249181526     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38832     Document Type: Review

References (64)

1. Lewis, D.A., and Sweet, R.A. 2009. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J. Clin. Invest. 119:706-716.
2. Mayberg, H.S. 2009. Targeted electrode-based modulation of neural circuits for depression. J. Clin. Invest. 119:717-725.
3. Martinowich, K., Schloesser, R.J., and Manji, H.K. 2009. Bipolar disorder: from genes to behavior pathways. J. Clin. Invest. 119:726-736.
4. Kalra, S.K., and Swedo, S.E. 2009. Children with obsessive-compulsive disorder: are they just "little adults"? J. Clin. Invest. 119:737-746.
5. Levitt, P., and Campbell, D.B. 2009. The genetic and neurobiological compass points toward common signaling dysfunctions in autism spectrum disorders. J. Clin. Invest. 119:747-754.
6. WHO. 2002. The world health report 2002 - reducing risks, promoting healthy life. WHO. Geneva, Switzerland. http://www.who.int/whr/2002/en/.
7. Kessler, R.C., et al. 2003. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 289:3095-3105.
8. Kessler, R.C., et al. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry. 62:593-602.
9. Institute of Medicine, Committee on Pathophysiology & Prevention of Adolescent & Adult Suicide, and Board on Neuroscience and Behavioral Health. 2002. Reducing suicide: a national imperative. S.K. Goldsmith, T.C. Pellmar, A.M. Kleinman, and W.E. Bunney, editors. National Academies Press. Washington, DC, USA. 496 pp.
10. Kung, H.C., Hoyert, D.L., Xu, J., and Murphy, S.L. 2008. Deaths: final data for 2005. Natl. Vital Stat. Rep. 56:1-120.
11. Colton, C.W., and Manderscheid, R.W. 2006. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev. Chronic Dis. 3:A42.
12. Lasser, K., et al. 2000. Smoking and mental illness: a population-based prevalence study. JAMA. 284:2606-2610.
13. Thomas, P. 2007. The stable patient with schizophrenia - from antipsychotic effectiveness to adherence. Eur. Neuropsychopharmacol. 17(Suppl. 2):S115-S122.
14. Cipriani, A., et al. 2005. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev. CD004185.
15. Butler, A.C., Chapman, J.E., Forman, E.M., and Beck, A.T. 2006. The empirical status of cognitivebehavioral therapy: a review of meta-analyses. Clin. Psychol. Rev. 26:17-31.
16. Shean, G.D. 2007. Recent developments in psychosocial treatments for schizophrenic patients. Expert Rev. Neurother. 7:817-827.
17. Regier, D.A., et al. 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 264:2511-2518.
18. Insel, T.R., and Quirion, R. 2005. Psychiatry as a clinical neuroscience discipline. JAMA. 294:2221-2224.
19. Bush, G. 1990. Presidential proclamation 6158. Library of Congress. http://www.loc.gov/loc/brain/ proclaim.html.
20. Meyer-Lindenberg, A.S., et al. 2005. Regionally specific disturbance of dorsolateral prefrontalhippocampal functional connectivity in schizophrenia. Arch. Gen. Psychiatry. 62:379-386.
21. Ressler, K.J., and Mayberg, H.S. 2007. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat. Neurosci. 10:1116-1124.
22. Graybiel, A.M., and Rauch, S.L. 2000. Toward a neurobiology of obsessive-compulsive disorder. Neuron. 28:343-347.
23. Rauch, S.L., Shin, L.M., and Phelps, E.A. 2006. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research - past, present, and future. Biol. Psychiatry. 60:376-382.
24. Shaw, P., et al. 2007. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc. Natl. Acad. Sci. U. S. A. 104:19649-19654.
25. Kandel, E.R., Schwartz, J.H., and Jessell, T.M. 2000. Principles of neural science. McGraw-Hill. New York, New York, USA. 1414 pp.
26. Wang, P.S., et al. 2005. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry. 62:603-613.
27. Warner, V., Mufson, L., and Weissman, M.M. 1995. Offspring at high and low risk for depression and anxiety: mechanisms of psychiatric disorder. J. Am. Acad. Child Adolesc. Psychiatry. 34:786-797.
28. Weissman, M.M., Warner, V., Wickramaratne, P., Moreau, D., and Olfson, M. 1997. Offspring of depressed parents. 10 years later. Arch. Gen. Psychiatry. 54:932-940.
29. Kessler, R.C., and Walters, E.E. 1998. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress. Anxiety. 7:3-14.
30. Cannon, T.D., et al. 2008. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry. 65:28-37.
31. Sullivan, M., et al. 2007. Response to joint attention in toddlers at risk for autism spectrum disorder: a prospective study. J. Autism Dev. Disord. 37:37-48.
32. Haberland, C. 2007. Clinical neuropathology: text and color atlas. Demos Medical Publishing. New York, New York, USA. 324 pp.
33. Aminoff, M.J. 2001. Neurology and general medicine. Churchill Livingstone. New York, New York, USA. 1147 pp.
34. Klein, R.J., et al. 2005. Complement factor H polymorphism in age-related macular degeneration. Science. 308:385-389.
35. Duerr, R.H., et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 314:1461-1463.
36. Saxena, R., et al. 2007. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 316:1331-1336.
37. Scott, L.J., et al. 2007. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 316:1341-1345.
38. Zeggini, E., et al. 2007. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 316:1336-1341.
39. Sklar, P., et al. 2008. Whole-genome association study of bipolar disorder. Mol. Psychiatry. 13:558-569.
40. O'Donovan, M.C., et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40:1053-1055.
41. Szatmari, P., et al. 2007. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39:319-328.
42. Xu, B., et al. 2008. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40:880-885.
43. Sebat, J., et al. 2007. Strong association of de novo copy number mutations with autism. Science. 316:445-449.
44. Walsh, T., et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 320:539-543.
45. Stefansson, H., et al. 2008. Large recurrent microdeletions associated with schizophrenia. Nature. 455:232-236.
46. Maier, W. 2008. Common risk genes for affective and schizophrenic psychoses. Eur. Arch. Psychiatry Clin. Neurosci. 258(Suppl. 2):37-40.
47. Chubb, J.E., Bradshaw, N.J., Soares, D.C., Porteous, D.J., and Millar, J.K. 2008. The DISC locus in psychiatric illness. Mol. Psychiatry. 13:36-64.
48. IMS Health Inc. 2007. IMS national sales perspectives 2007. http://www.imshealth.com.
49. Lieberman, J.A., et al. 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353:1209-1223.
50. Rosenheck, R., et al. 2003. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA. 290:2693-2702.
51. Jones, P.B., et al. 2006. Randomized controlled trial of the effect on Quality of Life of second- vs firstgeneration antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch. Gen. Psychiatry. 63:1079-1087.
52. Sikich, L., et al. 2008. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizoaffective disorder: findings from the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study. Am. J. Psychiatry. 165:1420-1431.
53. Rush, A.J. 2007. STAR*D: what have we learned? Am. J. Psychiatry. 164:201-204.
54. Walsh, B.T., Seidman, S.N., Sysko, R., and Gould, M. 2002. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 287:1840-1847.
55. Smith, L.A., Cornelius, V., Warnock, A., Bell, A., and Young, A.H. 2007. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord. 9:394-412.
56. King, M.L., Carson, C., and Holloran, P. 1998. A knock at midnight: inspiration from the great sermons of Reverend Martin Luther King, Jr. Warner Books. New York, New York, USA. 256 pp.
57. Halme, L., et al. 2006. Family and twin studies in inflammatory bowel disease. World J. Gastroenterol. 12:3668-3672.
58. Selby, J.V., et al. 1991. Concordance for dyslipidemic hypertension in male twins. JAMA. 265:2079-2084.
59. Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M., and Tuomilehto, J. 2003. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes. 52:1052-1055.
60. Seddon, J.M., Cote, J., Page, W.F., Aggen, S.H., and Neale, M.C. 2005. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch. Ophthalmol. 123:321-327.
61. Kendler, K.S., and Prescott, C.A. 1999. A population-based twin study of lifetime major depression in men and women. Arch. Gen. Psychiatry. 56:39-44.
62. Cardno, A.G., and Gottesman, I.I. 2000. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 97:12-17.
63. Kieseppa, T., Partonen, T., Haukka, J., Kaprio, J., and Lonnqvist, J. 2004. High concordance of bipolar I disorder in a nationwide sample of twins. Am. J. Psychiatry. 161:1814-1821.
64. Folstein, S.E., and Rosen-Sheidley, B. 2001. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat. Rev. Genet. 2:943-955.